<?xml version='1.0' encoding='utf8'?>
<text id="AMALGUM_academic_cancer" title="Inhibitory Effect of Oat Bran Ethanol Extract on Survival and Gemcitabine Resistance of Pancreatic Cancer Cells" shortTitle="cancer" author="Myoungjae Kim, Jeong-Geon Mun, Hyun  Jin Lee, So-Ri Son, Mi-Ja Lee, Ji-Ye Kee" type="academic" dateCollected="2019-11-03" sourceURL="https://www.mdpi.com/1420-3049/24/21/3829/htm" speakerList="none" speakerCount="0">
<head>
<s type="frag">
1.	LS	1.
Introduction	NN	introduction
</s>
</head>
<p>
<s type="decl">
Pancreatic	JJ	Pancreatic
cancer	NN	cancer
(	-LRB-	(
PC	NNP	PC
)	-RRB-	)
is	VBZ	be
the	DT	the
one	CD	one
of	IN	of
the	DT	the
most	RBS	most
aggressive	JJ	aggressive
and	CC	and
therapeutically	RB	therapeutically
ineffective	JJ	ineffective
malignant	JJ	malignant
cancers	NNS	cancer
.	.	.
</s>
<s type="decl">
Mortality	NN	mortality
due	JJ	due
to	IN	to
PC	NN	PC
is	VBZ	be
fourth	JJ	fourth
among	IN	among
the	DT	the
various	JJ	various
cancer	NN	cancer
types	NNS	type
worldwide	RB	worldwide
.	.	.
</s>
<s type="decl">
In	IN	in
<date when="2018">
2018	CD	2018
</date>
,	,	,
458,918	CD	458918
new	JJ	new
cases	NNS	case
and	CC	and
432,242	CD	432242
deaths	NNS	death
by	IN	by
PC	NNP	PC
were	VBD	be
recorded	VBN	record
worldwide	RB	worldwide
.	.	.
</s>
<s type="decl">
One	CD	one
of	IN	of
the	DT	the
primary	JJ	primary
reasons	NNS	reason
for	IN	for
the	DT	the
high	JJ	high
mortality	NN	mortality
is	VBZ	be
the	DT	the
difficulty	NN	difficulty
in	IN	in
early	JJ	early
diagnosis	NN	diagnosis
of	IN	of
the	DT	the
disease	NN	disease
because	IN	because
pancreas	NN	pancrea
is	VBZ	be
behind	IN	behind
the	DT	the
stomach	NN	stomach
and	CC	and
the	DT	the
patient	NN	patient
shows	VBZ	show
general	JJ	general
symptoms	NNS	symptom
such	JJ	such
as	IN	as
digestive	JJ	digestive
problems	NNS	problem
,	,	,
abdominal	JJ	abdominal
pain	NN	pain
,	,	,
and	CC	and
weight	NN	weight
loss	NN	loss
before	IN	before
metastasis	NN	metastasis
.	.	.
</s>
<s type="decl">
More	RBR	more
than	IN	than
80	CD	80
%	NN	%
of	IN	of
PC	NNP	PC
patients	NNS	patient
show	VBP	show
metastasis	NN	metastasis
at	IN	at
the	DT	the
time	NN	time
of	IN	of
diagnosis	NN	diagnosis
.	.	.
</s>
<s type="decl">
Despite	IN	despite
various	JJ	various
therapeutic	JJ	therapeutic
methods	NNS	method
,	,	,
the	DT	the
5-year	JJ	5-year
survival	NN	survival
rate	NN	rate
of	IN	of
PC	NNP	PC
is	VBZ	be
only	RB	only
8	CD	8
%	NN	%
and	CC	and
PC	NNP	PC
is	VBZ	be
projected	VBN	project
to	TO	to
be	VB	be
the	DT	the
second	JJ	second
leading	VBG	lead
cause	NN	cause
of	IN	of
cancer	NN	cancer
deaths	NNS	death
by	IN	by
<date when="2030">
2030	CD	2030
</date>
.	.	.
</s>
</p>
<p>
<s type="decl">
Gemcitabine	NNP	Gemcitabine
(	-LRB-	(
Gem	NNP	Gem
)	-RRB-	)
is	VBZ	be
approved	VBN	approve
as	IN	as
a	DT	a
first-line	JJ	first-line
chemotherapeutic	JJ	chemotherapeutic
drug	NN	drug
for	IN	for
PC	NNP	PC
treatment	NN	treatment
.	.	.
</s>
<s type="decl">
However	RB	however
,	,	,
the	DT	the
response	NN	response
rate	NN	rate
of	IN	of
Gem	NN	Gem
in	IN	in
PC	NNP	PC
patients	NNS	patient
is	VBZ	be
only	RB	only
12	CD	12
%	NN	%
and	CC	and
most	JJS	most
patients	NNS	patient
are	VBP	be
resistant	JJ	resistant
to	IN	to
Gem	NN	Gem
within	IN	within
a	DT	a
few	JJ	few
weeks	NNS	week
.	.	.
</s>
<s type="decl">
Less	RBR	less
than	IN	than
25	CD	25
%	NN	%
of	IN	of
PC	NNP	PC
patients	NNS	patient
benefit	VBP	benefit
from	IN	from
Gem	NN	Gem
treatment	NN	treatment
and	CC	and
the	DT	the
median	JJ	median
overall	JJ	overall
survival	NN	survival
is	VBZ	be
only	RB	only
6	CD	6
months	NNS	month
.	.	.
</s>
<s type="decl">
In	IN	in
order	NN	order
to	TO	to
overcome	VB	overcome
these	DT	this
limitations	NNS	limitation
of	IN	of
Gem	NNP	Gem
,	,	,
combinatorial	JJ	combinatorial
regimens	NNS	regimen
such	JJ	such
as	IN	as
folinic	JJ	folinic
acid	NN	acid
,	,	,
5-fluorouracil	NN	5-fluorouracil
,	,	,
irinotecan	NN	irinotecan
and	CC	and
oxaliplatin	NN	oxaliplatin
(	-LRB-	(
FOLFIRINOX	NNP	FolfiriNow
)	-RRB-	)
have	VBP	have
been	VBN	be
widely	RB	widely
used	VBN	use
to	TO	to
treat	VB	treat
PC	NN	PC
patients	NNS	patient
.	.	.
</s>
<s type="decl">
FOLFIRINOX	NNP	FolfiriNow
presents	VBZ	present
higher	JJR	high
response	NN	response
rates	NNS	rate
and	CC	and
its	PRP$	its
median	JJ	median
overall	JJ	overall
survival	NN	survival
is	VBZ	be
nearly	RB	nearly
12	CD	12
months	NNS	month
.	.	.
</s>
<s type="decl">
However	RB	however
,	,	,
this	DT	this
regimen	NN	regimen
shows	VBZ	show
considerable	JJ	considerable
adverse	JJ	adverse
effects	NNS	effect
such	JJ	such
as	IN	as
lower	JJR	low
blood	NN	blood
counts	NNS	count
,	,	,
fever	NN	fever
,	,	,
infection	NN	infection
,	,	,
diarrhea	NN	diarrhea
,	,	,
and	CC	and
weight	NN	weight
loss	NN	loss
.	.	.
</s>
<s type="decl">
Therefore	RB	therefore
,	,	,
development	NN	development
of	IN	of
new	JJ	new
chemotherapeutic	JJ	chemotherapeutic
drugs	NNS	drug
that	WDT	that
can	MD	can
overcome	VB	overcome
chemoresistance	NN	chemoresistance
and	CC	and
have	VB	have
less	RBR	less
adverse	JJ	adverse
effects	NNS	effect
on	IN	on
patients	NNS	patient
is	VBZ	be
needed	VBN	need
.	.	.
</s>
</p>
<p>
<s type="decl">
Oat	NNP	Oat
(	-LRB-	(
<hi rend="italic">
Avena	NNP	Avena
sativa	FW	sativa
</hi>
L.	FW	L.
)	-RRB-	)
is	VBZ	be
an	DT	a
important	JJ	important
cereal	NN	cereal
crop	NN	crop
of	IN	of
the	DT	the
family	NN	family
of	IN	of
Poaceae	NNP	Poaceae
grown	VBN	grow
worldwide	RB	worldwide
.	.	.
</s>
<s type="decl">
Oats	NNS	oat
have	VBP	have
various	JJ	various
advantages	NNS	advantage
;	:	;
they	PRP	they
require	VBP	require
less	JJR	less
nutrients	NNS	nutrient
to	TO	to
grow	VB	grow
than	IN	than
the	DT	the
wheat	NN	wheat
or	CC	or
the	DT	the
corn	NN	corn
.	.	.
</s>
<s type="decl">
Additionally	RB	additionally
,	,	,
as	IN	as
people	NNS	person
become	VBP	become
more	RBR	more
aware	JJ	aware
of	IN	of
their	PRP$	their
health	NN	health
,	,	,
more	JJR	more
people	NNS	person
are	VBP	be
consuming	VBG	consume
oats	NNS	oat
in	IN	in
the	DT	the
form	NN	form
of	IN	of
oatmeal	NN	oatmeal
,	,	,
granola	NN	granola
bars	NNS	bar
,	,	,
cookies	NNS	cooky
,	,	,
and	CC	and
beverages	NNS	beverage
.	.	.
</s>
<s type="decl">
Recent	JJ	Recent
studies	NNS	study
have	VBP	have
revealed	VBN	reveal
that	IN	that
oats	NNS	oat
possess	VBP	possess
beneficial	JJ	beneficial
health	NN	health
effects	NNS	effect
on	IN	on
aging	NN	aging
,	,	,
oxidant	NN	oxidant
,	,	,
cancer	NN	cancer
,	,	,
liver	NN	liver
injury	NN	injury
,	,	,
hypercholesterolemia	NN	hypercholesterolemia
,	,	,
and	CC	and
gastrointestinal	JJ	gastrointestinal
problems	NNS	problem
.	.	.
</s>
</p>
<p>
<s type="decl">
In	IN	in
this	DT	this
study	NN	study
,	,	,
the	DT	the
effects	NNS	effect
of	IN	of
ethanol	NN	ethanol
extract	NN	extract
from	IN	from
the	DT	the
oat	NN	oat
bran	NN	bran
(	-LRB-	(
OBE	NNP	OBE
)	-RRB-	)
on	IN	on
PC	NNP	PC
were	VBD	be
investigated	VBN	investigate
in	IN	in
vitro	NN	vitro
.	.	.
</s>
<s type="decl">
To	TO	to
confirm	VB	confirm
the	DT	the
anti-cancer	JJ	anti-cancer
effect	NN	effect
of	IN	of
OBE	NNP	OBE
on	IN	on
PC	NN	PC
cell	NN	cell
viability	NN	viability
,	,	,
colony	NN	colony
formation	NN	formation
,	,	,
cell	NN	cell
cycle	NN	cycle
distribution	NN	distribution
,	,	,
apoptosis	NN	apoptosis
,	,	,
and	CC	and
proteins	NNS	protein
were	VBD	be
evaluated	VBN	evaluate
.	.	.
</s>
<s type="decl">
Moreover	RB	moreover
,	,	,
the	DT	the
combination	NN	combination
effects	NNS	effect
of	IN	of
Gem	NNP	Gem
and	CC	and
OBE	NNP	OBE
on	IN	on
PC	NNP	PC
cells	NNS	cell
with	IN	with
acquired	VBN	acquire
resistance	NN	resistance
to	IN	to
Gem	NNP	Gem
was	VBD	be
investigated	VBN	investigate
to	TO	to
test	VB	test
if	IN	if
combination	NN	combination
therapy	NN	therapy
could	MD	could
overcome	VB	overcome
drug	NN	drug
resistance	NN	resistance
developed	VBN	develop
during	IN	during
cancer	NN	cancer
treatment	NN	treatment
.	.	.
</s>
</p>
</text>